Alexandros Sagkriotis

Alexandros Sagkriotis is an accomplished professional in the field of health economics and real-world evidence, currently serving as the Head of Global Strategic Evidence & Communications at LEO Pharma. Prior experience includes roles as Senior Director, RWE PAS Lead-Oncology at Gilead Sciences, Senior Director Evidence, Data & Insights at Novo Nordisk, and various leadership positions at Novartis, including RWE Head Oncology Region Europe and Executive Director Ophthalmology. Alexandros began their career as a Project Statistician at Boehringer Ingelheim. Educational background includes a Master of Science in Biometry/Biometrics from The University of Sheffield and additional studies at the University of Reading.